UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 173

Sortiert nach

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

The New England journal of medicine, 2011-06, Vol.364 (25), p.2405-2416

2011

Link zum Volltext

Verfügbarkeit prüfen

ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

The New England journal of medicine, 2014-05, Vol.370 (21), p.1973-1982

2014

Link zum Volltext

Verfügbarkeit prüfen

Telaprevir for Retreatment of HCV Infection

The New England journal of medicine, 2011-06, Vol.364 (25), p.2417-2428

2011

Link zum Volltext

Verfügbarkeit prüfen

Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis

PloS one, 2015-06, Vol.10 (6), p.e0132119-e0132119

2015

Link zum Volltext

Verfügbarkeit prüfen

First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: a case report

BMC infectious diseases, 2021-09, Vol.21 (1), p.1-958, Article 958

2021

Link zum Volltext

Verfügbarkeit prüfen

Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates

PloS one, 2021-01, Vol.16 (1), p.e0245091-e0245091

2021

Link zum Volltext

Verfügbarkeit prüfen

Serum sphingolipid levels associate with upcoming virologic events and HBV genotype D in a cohort of patients with HBeAg-negative HBV infection

PloS one, 2018-11, Vol.13 (11), p.e0207293-e0207293

2018

Link zum Volltext

Verfügbarkeit prüfen

The role of Enterococcus spp. and multidrug-resistant bacteria causing pyogenic liver abscesses

BMC infectious diseases, 2017-06, Vol.17 (1), p.450-450, Article 450

2017

Link zum Volltext

Verfügbarkeit prüfen

Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?

Annals of internal medicine, 2004-03, Vol.140 (5), p.370

Zeuzem, Stefan

2004

Link zum Volltext

Verfügbarkeit prüfen

Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy

PloS one, 2016-06, Vol.11 (6), p.e0156731-e0156731

2016

Link zum Volltext

Verfügbarkeit prüfen

Virologic Escape during Danoprevir (ITMN-191/RG7227) Monotherapy Is Hepatitis C Virus Subtype Dependent and Associated with R155K Substitution

Antimicrobial Agents and Chemotherapy, 2012-01, Vol.56 (1), p.271-279

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Conventional PCR with Real-Time PCR and Branched DNA-Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5

Journal of Clinical Microbiology, 2006-03, Vol.44 (3), p.729-737

2006

Link zum Volltext

Verfügbarkeit prüfen

Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection

PloS one, 2013-02, Vol.8 (2), p.e56991-e56991

2013

Link zum Volltext

Verfügbarkeit prüfen

Early Viral Kinetics of Telbivudine and Entecavir: Results of a 12-Week Randomized Exploratory Study with Patients with HBeAg-Positive Chronic Hepatitis B

Antimicrobial Agents and Chemotherapy, 2010-03, Vol.54 (3), p.1242-1247

2010

Link zum Volltext

Verfügbarkeit prüfen

IL28B single nucleotide polymorphisms in the treatment of hepatitis C

Journal of hepatology, 2011-09, Vol.55 (3), p.692-701

2011

Link zum Volltext

Verfügbarkeit prüfen

Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial

The Lancet infectious diseases, 2017-10, Vol.17 (10), p.1062-1068

2017

Link zum Volltext

Verfügbarkeit prüfen

New antiviral therapies in the management of HCV infection

Antiviral therapy, 2012-01, Vol.17 (5), p.771-783

2012

Link zum Volltext

Verfügbarkeit prüfen

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis

JAMA : the journal of the American Medical Association, 2012-12, Vol.308 (24), p.2584

2012

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Direct-acting Antivirals for Chronic Hepatitis C Virus Infection in People Who Inject Drugs or Receive Opioid Substitution Therapy: A Systematic Review and Meta-analysis

Clinical infectious diseases, 2020-05, Vol.70 (11), p.2355-2365

2020

Link zum Volltext

Verfügbarkeit prüfen

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

The New England journal of medicine, 2014-05, Vol.370 (20), p.1889-1898

2014

Link zum Volltext

Verfügbarkeit prüfen

Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography

Radiology, 2009-08, Vol.252 (2), p.595

2009

Link zum Volltext

Verfügbarkeit prüfen

Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy

Journal of hepatology, 2011-05, Vol.54 (5), p.887-893

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 173

Suche als RSS-Feed

Aktive Filter

SpracheDeutsch

SpracheJapanisch

ThemaInfectious Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(172)
Mit Volltextzugriff
(164)

Publikationsform

Artikel
(172)
Buchkapitel
(1)

Sprache

Englisch
(173)

Erscheinungsjahr

n.n

Thema

Science & Technology
(154)
Life Sciences & Biomedicine
(149)
Humans
(142)
Biological And Medical Sciences
(118)
Medical Sciences
(118)
Human Viral Diseases
(117)
Viral Diseases
(117)
Viral Hepatitis
(117)
Female
(100)
Male
(99)
Adult
(94)
Middle Aged
(92)
Antiviral Agents - Therapeutic Use
(89)
Hepatitis C, Chronic - Drug Therapy
(79)
Hepacivirus - Genetics
(76)
Gastroenterology & Hepatology
(73)
Antiviral Agents
(61)
Interferon-Alpha - Therapeutic Use
(57)
Pharmacology. Drug Treatments
(56)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

Telaprevir for Retreatment of HCV Infection

Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis

First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: a case report

Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study

Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates

Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial

Serum sphingolipid levels associate with upcoming virologic events and HBV genotype D in a cohort of patients with HBeAg-negative HBV infection

The role of Enterococcus spp. and multidrug-resistant bacteria causing pyogenic liver abscesses

Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?

Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy

Virologic Escape during Danoprevir (ITMN-191/RG7227) Monotherapy Is Hepatitis C Virus Subtype Dependent and Associated with R155K Substitution

Comparison of Conventional PCR with Real-Time PCR and Branched DNA-Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5

Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection

Early Viral Kinetics of Telbivudine and Entecavir: Results of a 12-Week Randomized Exploratory Study with Patients with HBeAg-Positive Chronic Hepatitis B

IL28B single nucleotide polymorphisms in the treatment of hepatitis C

Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial

New antiviral therapies in the management of HCV infection

Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis

Efficacy of Direct-acting Antivirals for Chronic Hepatitis C Virus Infection in People Who Inject Drugs or Receive Opioid Substitution Therapy: A Systematic Review and Meta-analysis

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography

Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy

Aktive Filter

Suchergebnisse filtern